NONOF - Novo Nordisk's parent eyes $7B annual investments by 2030: FT
2024-02-12 08:41:44 ET
More on Novo Nordisk
- Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript
- Biotech And Pharma Diversification Pays Off
- Novo Nordisk: Outlook For Weight Loss Drugs In 2024
- Booming weight-loss drug market to lift “pick-and-shovel” plays: Jefferies
- FTC likely to look at Catalent alternatives in review of Novo deal - report